News
Hosted on MSN1mon
Two-phase vaccination can boost the immune system against cancerIn another approach, the vaccine, which is protein-based or peptide-based, contains only the protein of the tumor antigen or at least parts of it. This synthetic method is faster, cheaper and less ...
Hosted on MSN1mon
Discovery of 500 tumor-specific cryptic peptides may guide future pancreatic cancer immunotherapiesThese therapies involve programming the T-cell receptor (TCR) of T cells to recognize a specific peptide, or antigen, found on tumor cells. There are many efforts underway to identify the most ...
These therapies involve programming the T-cell receptor (TCR) of T cells to recognize a specific peptide, or antigen, found on tumor cells. There are many efforts underway to identify the most ...
Trained immunity is a form of innate immune cell memory that is being developed as a novel immunotherapeutic approach for cancer treatment.
9d
Pharmaceutical Technology on MSNEnterome to advance EO2463 immunotherapy with $19m fundingEnterome has secured $19m in new private funding to progress its EO2463 OncoMimics immunotherapy, targeting iNHL.
Myrio's PHOX2B PC-CAR T therapy gains FDA approval for human trials, promising innovative treatment for patients with ...
In the field of cancer immunotherapy, unconventional T cells (UCTs) and Chimeric Antigen Receptor (CAR) T cells have emerged as promising areas of research ...
For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results